Luke Engelman
Pediatrics · Kansas City, MONPI 1669867008
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 24.2% of the total. Reporting peaked in 2024 at $511 and has fallen 67.1% since, to $168 in 2025. Among pediatrics clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 89 payments — averaging $19.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$410
- GSK$313
- Corium, LLC$169
- Sanofi Pasteur Inc.$96
- Cranial Technologies, Inc$92
- Merck$86
- plus $533 from 19 others
What the payments were for
- Food & beverage$1,697100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 7 | $410 |
| GSK | 22 | $313 |
| Corium, LLC | 10 | $169 |
| Sanofi Pasteur Inc. | 5 | $96 |
| Cranial Technologies, Inc | 6 | $92 |
| Merck | 6 | $86 |
| Tris Pharma Inc | 5 | $68 |
| Pfizer | 3 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $44 |
| Sobi, Inc | 2 | $44 |
| Seqirus USA Inc | 2 | $39 |
| Adlon Therapeutics L.p. | 3 | $37 |
| Kaleo, Inc. | 2 | $36 |
| Neos Therapeutics, LP | 2 | $29 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| Ironshore Pharmaceuticals Inc. | 1 | $23 |
| AstraZeneca | 1 | $18 |
| Novartis | 1 | $18 |
| Genentech USA, Inc. | 1 | $17 |
| Abbott | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
| UCB, Inc. | 1 | $15 |
| Sarepta Therapeutics, Inc. | 1 | $14 |
| Biomarin Pharmaceutical Inc. | 1 | $14 |
| Mylan Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$310
How this compares
$1,697 in reported general payments places this provider in the 90th percentile of 1,306 pediatrics providers in Missouri.
Other pediatrics in Kansas City
- Terri LuetjenKansas City$57K
- Sharon HumistonKansas City$41K
- Nikita RajeKansas City$23K
- Natasha BurgertKansas City$20K
- Jodi ShrobaKansas City$14K
- Rebecca FlynnKansas City$11K
- Brenda SnyderKansas City$10K
- Esosa AdahKansas City$8K
- Charles MoylanKansas City$5K
- Jordan JonesKansas City$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.